MX9707021A - Receptor de il-7. - Google Patents
Receptor de il-7.Info
- Publication number
- MX9707021A MX9707021A MX9707021A MX9707021A MX9707021A MX 9707021 A MX9707021 A MX 9707021A MX 9707021 A MX9707021 A MX 9707021A MX 9707021 A MX9707021 A MX 9707021A MX 9707021 A MX9707021 A MX 9707021A
- Authority
- MX
- Mexico
- Prior art keywords
- receptors
- receptor
- isolated
- dna
- regulate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se describe receptores aislados para IL-17, ADN que codifica dichos receptores y composiciones farmacéuticas hechas de los mismos. Los receptores aislados se pueden usar para regular una respuesta inmune.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41053595A | 1995-03-23 | 1995-03-23 | |
US53876595A | 1995-08-07 | 1995-08-07 | |
PCT/US1996/004018 WO1996029408A1 (en) | 1995-03-23 | 1996-03-21 | Il-17 receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9707021A true MX9707021A (es) | 1997-11-29 |
Family
ID=27021039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9707021A MX9707021A (es) | 1995-03-23 | 1996-03-21 | Receptor de il-7. |
Country Status (15)
Country | Link |
---|---|
US (9) | US5869286A (es) |
EP (1) | EP0817847B2 (es) |
JP (1) | JP4373495B2 (es) |
KR (1) | KR100467998B1 (es) |
AT (1) | ATE279517T1 (es) |
AU (1) | AU696775B2 (es) |
CA (1) | CA2215394C (es) |
DE (1) | DE69633617T3 (es) |
DK (1) | DK0817847T4 (es) |
ES (1) | ES2229264T5 (es) |
MX (1) | MX9707021A (es) |
NO (1) | NO974258L (es) |
NZ (1) | NZ306653A (es) |
PT (1) | PT817847E (es) |
WO (1) | WO1996029408A1 (es) |
Families Citing this family (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6274711B1 (en) * | 1993-06-14 | 2001-08-14 | Inserm, Institut National De La Sante Et De La Recherche Medicale | Purified mammalian CTLA-8 antigens and related reagents |
US6680057B1 (en) * | 1995-03-23 | 2004-01-20 | Immunex Corporation | Methods of treating autoimmune disease by administering interleukin-17 receptor |
PT817847E (pt) * | 1995-03-23 | 2005-02-28 | Immunex Corp | Receptor de il-17 |
US6074849A (en) * | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
AU727480B2 (en) * | 1995-07-19 | 2000-12-14 | Genetics Institute, Llc | Human CTLA-8 and uses of CTLA-8-related proteins |
US6902735B1 (en) | 1995-07-19 | 2005-06-07 | Genetics Institute, Llc | Antibodies to human IL-17F and other CTLA-8-related proteins |
ES2326347T3 (es) * | 1996-11-27 | 2009-10-07 | Immunex Corporation | Metodo para regular la produccion de oxido nitrico. |
US7005412B1 (en) * | 1996-11-27 | 2006-02-28 | Immunex Corporation | Method of treating ulcerative colitis and Crohn's disease using IL-17 receptor proteins |
US6579520B2 (en) * | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
US6849719B2 (en) | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
US6482923B1 (en) * | 1997-09-17 | 2002-11-19 | Human Genome Sciences, Inc. | Interleukin 17-like receptor protein |
DE69841140D1 (de) * | 1997-09-17 | 2009-10-22 | Human Genome Sciences Inc | Interleukin-17 rezeptor-ähnliches protein |
AU764006B2 (en) * | 1997-12-22 | 2003-08-07 | Stiftelsen Universitetsforskning Bergen (Unifob) | Method for disease prognosis based on Fc receptor genotyping |
EP1045905A2 (en) * | 1998-01-09 | 2000-10-25 | Immunex Corporation | Il-17rh dna and polypeptides |
ATE365800T1 (de) | 1998-05-15 | 2007-07-15 | Genentech Inc | Therapeutische verwendungen von il-17 homologe polypeptide |
US20050147609A1 (en) * | 1998-05-15 | 2005-07-07 | Genentech, Inc. | Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
US8133734B2 (en) * | 1999-03-16 | 2012-03-13 | Human Genome Sciences, Inc. | Kit comprising an antibody to interleukin 17 receptor-like protein |
CN1367688A (zh) * | 1999-04-14 | 2002-09-04 | 美国政府卫生与公众服务部 | 用于诱导对移植物的免疫耐受性的、包含免疫毒素和抑制树突细胞成熟的因子的组合物 |
WO2000064327A2 (en) * | 1999-04-26 | 2000-11-02 | Duke University | Inhibition of complement action |
US6936424B1 (en) * | 1999-11-16 | 2005-08-30 | Matritech, Inc. | Materials and methods for detection and treatment of breast cancer |
CA2391374A1 (en) * | 1999-12-23 | 2001-06-28 | Genentech, Inc. | Il-17 homologous polypeptides and therapeutic uses thereof |
EP1897946B1 (en) * | 1999-12-23 | 2012-07-11 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
JP2016047051A (ja) * | 1999-12-23 | 2016-04-07 | ジェネンテック, インコーポレイテッド | Il−17相同的ポリペプチドとその治療上の用途 |
JP2003526370A (ja) * | 2000-03-16 | 2003-09-09 | アムジェン インコーポレーテッド | Il−17レセプター様分子およびその使用 |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
CA2410083A1 (en) * | 2000-05-24 | 2001-11-29 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
AU2001272925A1 (en) | 2000-05-26 | 2001-12-11 | Immunex Corporation | Use of interleukin-4 antagonists and compositions thereof |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO2002004519A2 (en) * | 2000-07-06 | 2002-01-17 | Zymogenetics, Inc. | Murine cytokine receptor |
EP1332211A2 (en) * | 2000-07-26 | 2003-08-06 | ZymoGenetics, Inc. | Human cytokine receptor |
MXPA03003407A (es) * | 2000-10-18 | 2004-05-04 | Immunex Corp | Metodos para el tratamiento de artritis reumatoide usando antagonistas il-17. |
AU2002225714A1 (en) * | 2000-11-10 | 2002-05-21 | The Regents Of The University Of California | Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage |
PL376536A1 (pl) | 2002-08-28 | 2006-01-09 | Immunex Corporation | Kompozycje i sposoby leczenia chorób układu sercowo-naczyniowego |
EP2322200A3 (en) * | 2002-10-29 | 2011-07-27 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
JP4441170B2 (ja) * | 2002-11-28 | 2010-03-31 | 独立行政法人理化学研究所 | S12リボソームタンパク質に変異を有する大腸菌細胞抽出液及びそれを用いる無細胞系によるタンパク質の製造方法 |
WO2005028433A2 (en) * | 2003-09-15 | 2005-03-31 | Research Development Foundation | CRIPTO ANTAGONISM OF ACTIVIN AND TGF-β SIGNALING |
US20080014172A1 (en) * | 2004-05-28 | 2008-01-17 | Applied Research Systems Ars Holding N.V. | Use of Il-17 in the Treatment of Fertility-Related Disorders |
AU2005254998B2 (en) | 2004-06-10 | 2011-10-27 | Zymogenetics, Inc. | Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation |
GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
US20060068434A1 (en) * | 2004-09-21 | 2006-03-30 | Jay Stoerker | Methods and compositions for detecting cancer using components of the U2 spliceosomal particle |
EA200700823A1 (ru) * | 2004-10-18 | 2008-02-28 | Займодженетикс, Инк., Сша | Растворимый zcytor21, анти-zcytor21 антитела и связывающие партнёры и способы применения при воспалении |
JP4590249B2 (ja) * | 2004-11-17 | 2010-12-01 | 独立行政法人理化学研究所 | 糖タンパク質合成用の無細胞タンパク質合成システム |
JP4868731B2 (ja) | 2004-11-17 | 2012-02-01 | 独立行政法人理化学研究所 | 哺乳動物培養細胞由来の無細胞タンパク質合成システム |
JP4787488B2 (ja) * | 2004-11-19 | 2011-10-05 | 独立行政法人理化学研究所 | 直鎖状鋳型dnaを用いた無細胞タンパク質合成方法及びそのための細胞抽出液 |
PE20061391A1 (es) * | 2005-02-14 | 2007-01-09 | Wyeth Corp | Anticuerpos para interleucina-17f y otros antagonistas de la senalizacion de il-17f |
JP2008532493A (ja) * | 2005-02-14 | 2008-08-21 | ワイス | Il−17fとil−17rとの間の相互作用の特性解析 |
GB0504436D0 (en) * | 2005-03-03 | 2005-04-06 | Glaxosmithkline Biolog Sa | Vaccine |
EA012801B1 (ru) | 2005-06-14 | 2009-12-30 | Эмджен Инк. | Самобуферирующиеся композиции белков |
ES2333260T3 (es) | 2005-09-01 | 2010-02-18 | Schering Corporation | Uso de antagonistas de il-23 e il-17 para tratar la enfermedad inflamatoria ocular autoinmunologica. |
US20070249533A1 (en) | 2005-09-28 | 2007-10-25 | Levin Steven D | Il-17a and il-17f antagonists and methods of using the same |
JP2009526084A (ja) | 2006-02-10 | 2009-07-16 | ザイモジェネティクス, インコーポレイテッド | 可溶性IL−17RCx4および炎症における使用法 |
EP1996616A1 (en) * | 2006-02-10 | 2008-12-03 | Zymogenetics, Inc. | Truncated il-17ra soluble receptor and methods of using in inflammation |
JP2009541338A (ja) * | 2006-06-19 | 2009-11-26 | ワイス | Il−22およびil−17の調節方法 |
US7767206B2 (en) * | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
FR2908999B1 (fr) * | 2006-11-29 | 2012-04-27 | Biomerieux Sa | Nouveau medicament destine a l'inhibition, la prevention ou le traitement de la polyarthrite rhumatoide. |
FR2910324B1 (fr) * | 2006-12-21 | 2009-03-06 | Biomerieux Sa | Nouveau medicament pour le traitement d'un cancer gastrique |
EP2417974A1 (en) | 2007-02-28 | 2012-02-15 | Schering Corporation | Combination therapy for treatment of immune disorders |
EP2125880A1 (en) | 2007-03-26 | 2009-12-02 | Zymogenetics, Inc. | Soluble il-17ra/rc fusion proteins and related methods |
TW200902064A (en) * | 2007-03-28 | 2009-01-16 | Wyeth Corp | Methods and compositions for modulating IL-17F/IL-17A biological activity |
CA2684329A1 (en) * | 2007-04-20 | 2008-10-30 | Amgen Inc. | Identification and method for using the pre-ligand assembly domain of the il-17 receptor |
EP2182943B1 (en) * | 2007-07-23 | 2016-10-26 | Janssen Biotech, Inc. | Methods and compositions for treating fibrosis related disorders using il-17 antagonists |
EP2666783B1 (en) * | 2007-09-25 | 2019-06-26 | Genzyme Corporation | Compositions for inhibiting interleukin-23 pathways |
DK2213747T3 (da) * | 2007-11-05 | 2021-08-09 | Riken | Fremgangsmåde til fremstilling af membranprotein |
BRPI0907196B1 (pt) * | 2008-02-21 | 2021-05-25 | Kirin-Amgen Inc | Uso de um antagonista de il-17ra-il-17rb |
NZ600584A (en) * | 2008-05-05 | 2014-05-30 | Novimmune Sa | Anti-il 17a/il-17f cross-reactive antibodies and methods of use thereof |
EP2166358A1 (en) * | 2008-09-17 | 2010-03-24 | Fundacio Institut de Recerca de l'Hospital Universitari Vall d'Hebron | Differential diagnostic biomarkers of stroke mimicking conditions and methods of use thereof |
US20100233270A1 (en) | 2009-01-08 | 2010-09-16 | Northwestern University | Delivery of Oligonucleotide-Functionalized Nanoparticles |
CA2755336C (en) | 2009-03-20 | 2015-07-14 | Amgen Inc. | Carrier immunoglobulins and uses thereof |
MX2011011729A (es) | 2009-05-05 | 2012-04-10 | Novimmune Sa | Anticuerpo anti il-17f y metodos de uso de los mismos. |
CN102648002A (zh) * | 2009-10-10 | 2012-08-22 | 斯坦福大学托管董事会 | Il-17家族细胞因子组合物及用途 |
TW201117824A (en) | 2009-10-12 | 2011-06-01 | Amgen Inc | Use of IL-17 receptor a antigen binding proteins |
RS59743B1 (sr) | 2010-01-15 | 2020-02-28 | Kirin Amgen Inc | Formulacija antitela protiv il-17ra i terapeutski režimi za lečenje psorijaze |
EP2552967A4 (en) | 2010-04-02 | 2014-10-08 | Amunix Operating Inc | BINDING FUSION PROTEINS, BINDING FUSION PROTEIN MEDICINAL CONJUGATES, XTEN MEDICAMENT CONJUGATES, AND METHOD FOR THEIR PREPARATION AND USE |
JP6159660B2 (ja) | 2010-09-22 | 2017-07-05 | アムジエン・インコーポレーテツド | 担体としての免疫グロブリンおよびその使用 |
EP3498323B1 (en) | 2011-04-20 | 2022-07-13 | Amgen Inc. | Autoinjector apparatus |
WO2013016220A1 (en) | 2011-07-22 | 2013-01-31 | Amgen Inc. | Il-17 receptor a is required for il-17c biology |
US9284283B2 (en) | 2012-02-02 | 2016-03-15 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating IL-17 |
TWI639449B (zh) | 2013-03-15 | 2018-11-01 | 美商安美基公司 | 用於注射器之匣盒 |
US10092703B2 (en) | 2013-03-15 | 2018-10-09 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
KR102530900B1 (ko) | 2014-03-31 | 2023-05-12 | 암젠 케이-에이, 인크. | 손발톱 및 두피 건선의 치료 방법 |
JP6722951B2 (ja) | 2015-07-31 | 2020-07-15 | 国立研究開発法人理化学研究所 | 膜タンパク質の製造方法およびその利用 |
CA3023451A1 (en) | 2016-05-06 | 2017-11-09 | Exicure, Inc. | Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna |
US11285191B2 (en) | 2016-07-26 | 2022-03-29 | The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Immunostimulatory compositions and uses therefor |
WO2018201090A1 (en) | 2017-04-28 | 2018-11-01 | Exicure, Inc. | Synthesis of spherical nucleic acids using lipophilic moieties |
CA3084486A1 (en) | 2017-11-16 | 2019-05-23 | Amgen Inc. | Autoinjector with stall and end point detection |
CN114107385A (zh) * | 2019-01-17 | 2022-03-01 | 百奥赛图(北京)医药科技股份有限公司 | 人源化转基因动物 |
CN114401993A (zh) | 2019-09-11 | 2022-04-26 | 博世健康爱尔兰有限公司 | 使用il-17ra抗体治疗非酒精性脂肪肝疾病(nafld)的方法 |
JP2022176672A (ja) * | 2021-05-17 | 2022-11-30 | 国立大学法人北海道大学 | ペプチド及び医薬用組成物 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5703088A (en) * | 1989-08-21 | 1997-12-30 | Beth Israel Deaconess Medical Center, Inc. | Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses |
US5716805A (en) * | 1991-10-25 | 1998-02-10 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
US6562333B1 (en) * | 1993-06-14 | 2003-05-13 | Schering Corporation | Purified mammalian CTLA-8 antigens and related reagents |
US6274711B1 (en) * | 1993-06-14 | 2001-08-14 | Inserm, Institut National De La Sante Et De La Recherche Medicale | Purified mammalian CTLA-8 antigens and related reagents |
PT817847E (pt) * | 1995-03-23 | 2005-02-28 | Immunex Corp | Receptor de il-17 |
US6074849A (en) * | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
ES2326347T3 (es) * | 1996-11-27 | 2009-10-07 | Immunex Corporation | Metodo para regular la produccion de oxido nitrico. |
MXPA03003407A (es) * | 2000-10-18 | 2004-05-04 | Immunex Corp | Metodos para el tratamiento de artritis reumatoide usando antagonistas il-17. |
-
1996
- 1996-03-21 PT PT96912451T patent/PT817847E/pt unknown
- 1996-03-21 WO PCT/US1996/004018 patent/WO1996029408A1/en active IP Right Grant
- 1996-03-21 CA CA2215394A patent/CA2215394C/en not_active Expired - Lifetime
- 1996-03-21 DE DE69633617T patent/DE69633617T3/de not_active Expired - Lifetime
- 1996-03-21 KR KR1019970706470A patent/KR100467998B1/ko not_active IP Right Cessation
- 1996-03-21 JP JP52865596A patent/JP4373495B2/ja not_active Expired - Lifetime
- 1996-03-21 ES ES96912451T patent/ES2229264T5/es not_active Expired - Lifetime
- 1996-03-21 DK DK96912451T patent/DK0817847T4/da active
- 1996-03-21 NZ NZ306653A patent/NZ306653A/xx not_active IP Right Cessation
- 1996-03-21 AT AT96912451T patent/ATE279517T1/de active
- 1996-03-21 EP EP96912451A patent/EP0817847B2/en not_active Expired - Lifetime
- 1996-03-21 AU AU55263/96A patent/AU696775B2/en not_active Expired
- 1996-03-21 US US08/620,694 patent/US5869286A/en not_active Expired - Lifetime
- 1996-03-21 MX MX9707021A patent/MX9707021A/es unknown
-
1997
- 1997-09-15 NO NO974258A patent/NO974258L/no unknown
-
1998
- 1998-02-11 US US09/022,259 patent/US6191104B1/en not_active Expired - Lifetime
- 1998-02-11 US US09/022,253 patent/US6096305A/en not_active Expired - Lifetime
- 1998-02-11 US US09/022,257 patent/US6197525B1/en not_active Expired - Lifetime
- 1998-02-11 US US09/022,260 patent/US6100235A/en not_active Expired - Lifetime
- 1998-02-11 US US09/022,255 patent/US6072033A/en not_active Expired - Lifetime
- 1998-02-12 US US09/022,696 patent/US6072037A/en not_active Expired - Lifetime
-
2007
- 2007-09-19 US US11/901,904 patent/US20090068737A1/en not_active Abandoned
-
2010
- 2010-03-11 US US12/722,477 patent/US20100233186A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20090068737A1 (en) | 2009-03-12 |
US6096305A (en) | 2000-08-01 |
EP0817847A1 (en) | 1998-01-14 |
DE69633617T2 (de) | 2005-11-03 |
EP0817847B2 (en) | 2009-09-09 |
NZ306653A (en) | 1999-03-29 |
US6072033A (en) | 2000-06-06 |
US6072037A (en) | 2000-06-06 |
PT817847E (pt) | 2005-02-28 |
DK0817847T3 (da) | 2005-02-14 |
US5869286A (en) | 1999-02-09 |
ES2229264T3 (es) | 2005-04-16 |
EP0817847B1 (en) | 2004-10-13 |
JP4373495B2 (ja) | 2009-11-25 |
AU696775B2 (en) | 1998-09-17 |
CA2215394A1 (en) | 1996-09-26 |
US20100233186A1 (en) | 2010-09-16 |
DE69633617T3 (de) | 2010-05-20 |
CA2215394C (en) | 2011-04-26 |
ES2229264T5 (es) | 2009-12-17 |
KR19980703061A (ko) | 1998-09-05 |
ATE279517T1 (de) | 2004-10-15 |
DK0817847T4 (da) | 2009-10-05 |
US6191104B1 (en) | 2001-02-20 |
NO974258L (no) | 1997-11-24 |
JPH11503309A (ja) | 1999-03-26 |
KR100467998B1 (ko) | 2005-11-25 |
WO1996029408A1 (en) | 1996-09-26 |
US6100235A (en) | 2000-08-08 |
AU5526396A (en) | 1996-10-08 |
DE69633617D1 (de) | 2004-11-18 |
US6197525B1 (en) | 2001-03-06 |
NO974258D0 (no) | 1997-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9707021A (es) | Receptor de il-7. | |
LU91758I9 (es) | ||
EP0837927A4 (en) | MONOCLONAL MONKEY ANTIBODIES AGAINST HUMANE B7.1 AND / OR B7.2 ANTIGEN, PRIMATIZED DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS | |
MX9700223A (es) | Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida. | |
EP0812212A4 (en) | COMPOSITIONS FOR ADMINISTRATION OF ANTIGENS | |
ID28003A (id) | Turunan-turunan adamantana | |
ZA965294B (en) | Substituted 4-phenylaminothiazoles, their process of preparation and the pharmaceutical compositions containing them. | |
ATE360032T1 (de) | Cystein-reiche rezeptoren-train | |
BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
IL138424A0 (en) | Covalently reactive antigen analogs and pharmaceutical compositions containing the same | |
CA2200423A1 (en) | Novel estrogen receptor | |
AU2002359727A1 (en) | Fused cyclic modulators of nuclear hormone receptor function | |
WO2002000653A3 (en) | Fused cyclic compounds as modulators of nuclear hormone receptor function | |
MX9602445A (es) | Pigmentos dorados. | |
IL117459A (en) | Dna encoding human papillomavirus type 18 | |
DE59602303D1 (de) | Redispergierbare dispersionspulver-zusammensetzung | |
AU3711597A (en) | A novel galanin receptor | |
BG101849A (en) | Bicyclic tachyquinine antagonists, their preparation and use in pharmaceutical compositions | |
DE3268160D1 (en) | Medicaments based on algae, and formulations thereof | |
BG102229A (en) | Endothelium receptor antagonists | |
WO1999012945A3 (en) | Hydrophobic glycosylamine derivatives, compositions, and methods for use | |
MXPA02012015A (es) | Ligandos de receptores para integrinas. | |
NZ326769A (en) | High-content famciclovir tablets | |
PL366565A1 (en) | Fused cyclic modulators of nuclear hormone receptor function | |
DE69614552D1 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE |